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Abstract 
The coordination of cell proliferation and differentiation is central to the 
development and maintenance of tissues, while its dysregulation underlies the 
transition to diseased states. By combining lineage tracing with transcriptional 
profiling and marker-based assays, statistical methods are delivering insights into the 
dynamics of stem cells and their developmental precursors. These studies have 
provided evidence for molecular heterogeneity and fate priming, and have revealed 
a role for stochasticity in stem cell fate, refocusing the search for regulatory 
mechanisms. At the same time, they present a quantitative platform to study the 
initiation and progression of disease. Here, we review how quantitative lineage 
tracing strategies are shaping our understanding of the cellular mechanisms of tissue 
development, maintenance and disease.  
 
Main text 
To address the factors that control the development and maintenance of tissues, 
emphasis has been placed on defining the molecular mechanisms that regulate cell 
fate choice. Through marker-based assays and gene knockouts, significant progress 
has been made in resolving elements of the gene regulatory circuitry and signaling 
pathways that coordinate stem and progenitor cell activity. However, cells function 
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in a heterogeneous and dynamic environment where gene expression levels adjust in 
response to promoter activity and environmental cues. Therefore, to define the 
mechanisms that underpin cell fate, transcriptional information must be integrated 
with dynamic measures that address functional behaviour.  
In the earliest form of lineage tracing, tritiated thymidine incorporation was used as 
a surrogate clonal marker [1]. Using such methods, C.P. LeBlond, a pioneer of 
modern stem cell biology, made significant progress in defining stem cell identity in a 
variety of epithelial tissues [2–4]. Later, lineage tracing strategies based on the 
incorporation of marker genes by electroporation [5] and lentiviral transfection [6], 
provided the means to impart hereditary marks on cells. However, it was not until 
the advent of transgenic animal technology that it became possible to trace the fate 
of individual cells and their progeny using targeted promoters. These days, intra-vital 
imaging platforms are providing access to continuous-time lineage data [7–9], while 
single-cell DNA sequencing methods offer the potential to resolve phylogenies in 
human tissues [10–12]. 
Advances in lineage tracing and molecular profiling techniques provide access to 
information at the cellular and molecular scale. Yet the integration of these 
measures into new mechanistic insights presents a formidable challenge. In recent 
years, the development of quantitative statistical methods, based on concepts from 
statistical physics and mathematics, are gaining traction in biology. These 
approaches, which place emphasis on “emergent behaviour” and scaling 
phenomena, provide constraints on the molecular mechanisms that regulate 
proliferative activity, fate choice and the collective dynamics of stem and progenitor 
cell populations. Beginning with a review of current lineage tracing strategies, here 
we provide an overview of how quantitative analysis of clonal data can be used to 
define mechanisms of cell fate choice in tissue development, maintenance and 
diseased states.  
Lineage tracing strategies 
Through advances in transgenics, multiple tracing strategies are available [13,14]. In 
the Cre-lox system, the expression of Cre recombinase is placed under the control of 
a cell-specific promoter [15]. Following the administration of a drug-inducing agent, 
the transient expression of Cre leads to the excision of a stop cassette, resulting in 
the activation of a fluorescent reporter gene. By using targeted promoters, this 
method allows the controlled labelling of distinct subpopulations at clonal or mosaic 
density (Figure 1a,b). By coupling the fluorescent reporter to the activation of an 
oncogene, such methods are increasingly deployed to trace steps in tumour 
progression, from initiation to invasion [16].  
Despite their power, the reliability of genetic labelling assays may be compromised 
by (the lack of) promoter specificity, toxicity of the Cre enzyme or drug-inducing 
agent [17], and the faithful identification of clones. In the process of tissue or 
tumour development, large-scale cell rearrangements may lead to the fragmentation 
of labelled clones into disconnected cell clusters. Similarly, at non-clonal labelling 
density, initially separate clones may merge and form cohesive groups of labelled 
cells of non-clonal origin. Although the impact of clone merger and fragmentation 
events may be mitigated by multicolour (Brainbow or Confetti) reporter constructs 
[18,19], such effects cannot be eradicated. However, recent progress in the 
development of statistical analytical methods provide rigorous quantitative 
measures that allow lineage relationships to be inferred even from non-clonal 
density labelling [20]. 
Although clonal tracing studies provide indirect insight into the fate of marked cells, 
as a static measure based on the analysis of fixed samples, detailed information on 
individual fate histories is invariably lost. In the Mosaic Analysis with Double Marker 
(MADM) system, through Cre-induced mitotic recombination, fluorescent reporter 
genes of distinct colour can be activated in sister cells (Figure 1c,d), allowing 
definitive lineage information to be recovered [21]. Moreover, by correlating the 
expression of an oncogene with only one of the fluorescent proteins, the MADM 
system allows the mutual interaction of mutant and wild-type clones to be studied in 
situ.  
The dispersion of cells in the blood system renders traditional “few-colour” labelling 
strategies impractical as a lineage tracing system. Here, efforts have been made to 
increase the spectrum of lineage labels so that clonal information can be recovered. 
To this end, approaches have been developed based on the incorporation of genetic 
“barcodes” using lentiviral vectors [22] as well as the activation of transposons [23].  
To study proliferation kinetics and resolve slow-cycling cell populations, emphasis 
has been placed on the H2B–GFP system in which the expression of GFP fused to 
histone 2B is made dependent on the presence of Doxycycline (DOX) [24]: In this 
approach, H2B-GFP is homogeneously expressed in dividing cells. Upon DOX 
administration, H2B-GFP production is repressed such that, post-induction, the 
cellular concentration of H2B-GFP is approximately halved on division (Figure 1e,f). 
By measuring the intensity of the GFP signal, this pulse-chase strategy allows the 
distribution of cell divisions to be resolved, both at the population level (by FACS) 
and spatially (by microscopy). Although such methods have been used to identify 
quiescent cell populations [25–28], their potential to probe cellular dynamics and 
fate behaviour of actively cycling progenitors [29,30] remains underexploited. 
Following advances in multi-photon microscopy, methods based on intra-vital 
imaging have enabled lineage information and spatial dynamics of epithelial cell 
populations to be resolved in vivo (Figure 1g,h) [7–9]. Technical limitations restrict 
continuous live-imaging of mouse models to a few days. Although time-lapse 
imaging over discrete time intervals allows the dynamics of individual clones to be 
tracked over periods of months or more, ambiguities in the intermediate fate 
histories prohibit the faithful reconstruction of lineage histories. Nevertheless, with 
the ability to correlate cell fate choice with position, these approaches have revealed 
evidence of dynamic heterogeneity, lineage priming and the flexibility of cellular 
states, providing new insights into the molecular mechanisms regulating stem cell 
identity and lineage commitment [31–34]. 
Finally, to trace cell fate behaviour in human tissues, attention has focused on the 
ability of naturally occurring DNA mutations to serve as a hereditary label (Figure 1i). 
In one approach, the accumulation of mitochondrial DNA mutation (mtDNA) [35,36] 
has been used as a surrogate clonal marker [37,38]. In a related approach, the 
acquisition of single nucleotide polymorphisms have been used as a hereditary mark 
allowing the allele frequency of clonally related cells to be recovered by exome deep 
sequencing [11,22,39]. Further, advances in single-cell DNA sequencing offer the 
potential to recover phylogenic information, with applications to both normal and 
diseased tissues [40]. However, although these approaches provide a valuable 
window on cell dynamics in human tissues, the neutrality of mtDNA and DNA 
mutations call into question their reliability.  
Clonal distributions as a record of cell fate choice 
Although the lineage potential and proliferative capacity of labelled cells is reflected 
in clone size and composition, for a given clone, such static measures can rarely 
select from among the multiplicity of potential fate histories the one was actually 
followed. However, if cell fate behaviour is conserved across a subpopulation, by 
recovering the distribution of clone size and cell composition from a statistical 
ensemble, analytical methods based on population dynamics and inference 
techniques can be used to select the model that best predicts the experimental 
outcome. By analogy, the balance of a weighted die cannot be discerned from a 
single throw; but it can be resolved from an analysis of a statistical ensemble of 
throws. Of course, with the innate complexity of a developing tissue, the challenge 
of deciphering pattern of cell fate choice from static clonal data may be better 
compared to recovering the rules of chess from the statistical ensemble of 
chessboard configurations! 
Fortunately, in many cases, the convergence of clone size distributions onto 
stereotypic behaviours allows rigorous aspects of cell dynamics to be inferred. For 
example, to achieve homeostasis, the maintenance of cycling adult tissues must rely 
on the activity of an equipotent stem cell population in which cell proliferation is 
perfectly balanced by differentiation. Such fate asymmetry may be invariant, 
achieved at the level of each and every stem cell division. Alternatively, asymmetry 
may be achieved only at the level of the population where chance stem cell loss 
through differentiation is compensated by cell duplication so that the overall stem 
cell number remains constant (Figure 2a). Through this process of “neutral” cell 
competition, the chance        of a marked cell giving rise to a surviving clone with 
a size larger than   cells after a time   converges onto a “scaling” form,        
           , with        the average clone size and   the scaling function [41], i.e. 
while the average clone size increases to compensate for the chance differentiation 
and loss of clones (Figure 2b,c), the chance of finding a clone with a size larger than 
some multiple of the average remains constant over time (Figure 2d,e). Through the 
particular form of the scaling function,  , it is possible to determine whether the 
balance between such stochastic stem cell loss and replacement follows from cell-
autonomous regulation or is mediated by extrinsic cues such as neutral competition 
for limited niche access.  
Such approaches have been successful in resolving fate behaviour in multiple 
epithelial tissue types [42] including interfollicular epidermis [29,43], 
oesophagus[44], testis [45] and trachea [46], and have explained the nature of stem 
cell dynamics in the intestinal crypt and the drift towards clonal “fixation”[47] . 
However, despite the success of these quantitative methods, such long-term scaling 
dependences may mask short-term bias in survival potential (fate priming) and the 
sub-lineage dependences of stem cell progeny. To dissect information on transient 
fate bias, emphasis must be placed on short-term clone size dependences and the 
combination of targeted promoters, which offer a “stereoscopic” perspective on 
lineage behaviour, or live-imaging approaches that can resolve the complete lineage 
history of marked cells [32,34]. 
Outside homeostasis, the dynamics of clonal evolution is less restricted. As a result, 
the resolution of cell fate behaviour has proved more challenging. These difficulties 
are exacerbated by the escalation of clone merger and fragmentation events in 
growth. Nevertheless, when clonal data can be recovered, quantitative information 
on lineage potential can often be deciphered. In one example, by targeting radial 
glial-like (RGL) precursors using the MADM labelling system, quantitative analysis of 
sister clone size dependence has shown that mouse cortical neurogenesis relies on a 
remarkably deterministic cell-autonomous programme [48]. Through the correlation 
of sister clone sizes, these studies revealed that the entry of RGLs into their 
neurogenesis is not sporadic, but is tightly-regulated so that, in their proliferative 
phase, RGLs move sequentially through a defined cascade of symmetrical divisions. 
Following entry into neurogenesis, RGLs then make a series of invariant asymmetric 
cell divisions, giving rise to a “quantal” neuronal output before finally entering into 
gliogenesis.  
In a second case study, a multicolour Confetti labelling system has been used to 
address the lineage and proliferative potential of early Mesp1 expressing cells in the 
developing mouse heart (Figure 3a) [49,50]. Here, one or few cells were labelled at 
several time points during gastrulation and their fate was analysed at later times 
when key stages of cardiac development were completed. In this case, large-scale 
tissue rearrangements lead to the merger and fragmentation of clones, making 
lineage analysis problematic (Figure 3b). Nevertheless, using statistical inference 
methods, clonal information could be inferred from clone fragments during late 
stage development, from which the early lineage specification of Mesp1 expression 
precursors was resolved (Figure 3c). As in this case, clonal information is often 
obtained from sections, which renders the reconstruction of the full clone size 
distribution unfeasible. However, by taking into account potential cell migratory 
processes between adjacent sections, further information on cell fate behaviour of 
precursor cells can be recovered from sectional data alone (Figure 3d). In the present 
case, quantitative analysis of the sectional clone size distribution (Figure 3e) revealed 
that cardiac development follows from the early lineage restriction of some 250 
Mesp1 precursors that, like RGLs, are specified with largely defined proliferative 
potential.  
Alongside normal developmental processes, genetic labelling approaches have been 
used to study tumour initiation following oncogenic transformation. In contrast to 
the coordinated and predictable lineage progression of cell precursors through 
development, pre-neoplastic transformation and invasive carcinoma follow from a 
sequence of sporadic transitions that create the hallmark heterogeneity of the 
tumour environment. On this background, the value of quantitative clonal fate 
studies may be largely restricted to the earliest phases of transformation, where 
much of the cell regulatory programme remains intact. Pioneering lineage studies 
based on lineage tracing following carcinogen treatment [51] or the clonal activation 
of oncogenes [52] have been used to quantify the bias in stem and progenitor cell 
fate of mutant cells over their wild-type neighbours providing a basis to understand 
the nature of field transformation. For example, the quantitative analysis of clonal 
evolution following the activation of K-ras or the deletion of Apc have been used to 
quantify the existence and degree of stem cell fate bias in the mouse intestinal crypt 
[53,54]. Similarly, quantitative lineage tracing assays have been used to investigate 
how the stochastic fate behaviour of oesophageal progenitors are perturbed by the 
activation of a mutation in the Notch signalling pathway [44]. 
Perspectives 
To address the mechanisms that regulate the maintenance of cycling adult tissues, 
emphasis has been placed on models in which stem cells, defined by signature 
marker expression, are individually long-lived and progress one-way through a 
proliferative hierarchy. However, by targeting the functional behaviour of cells, 
quantitative lineage tracing studies have shown that stem cells are not individually 
long-lived, but are frequently lost and replaced [55]. Studies based on intra-vital 
imaging show that stem cells are often not homogeneous but, through signals from 
the niche, they transit reversibly between states primed for duplication and loss 
[7,32,56]. Moreover, lineage tracing studies using cell-specific promoters have 
shown that cells normally committed to differentiation may be recruited back into 
the stem cell compartment following injury [57]. Together these studies have 
questioned the molecular basis of stem cell heterogeneity, fate stochasticity and 
plasticity of cellular states.  
Through advances in genetic lineage tracing, DNA sequencing, single-cell expression 
profiling and genome editing, the ability to probe and manipulate cellular states has 
never been greater. However, applied in isolation, such techniques offer only limited 
insight: From the relative abundance of mutant alleles we learn little of the cellular 
mechanisms that initiate and promote tumour progression. From the transcriptional 
profile of stem cells we learn little about lineage relationships and functional fate 
dependences. And from the “rules” of cell fate choice, we learn little of the 
molecular circuitry that condition lineage potential and fate decisions. Future 
progress in developmental and cancer biology will rely on the integration of these 
complementary techniques, a major challenge that will draw as much on new 
conceptual and theoretical insights as technological advances.  
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Figure Legends 
Figure 1. Current in vivo lineage tracing methods. (a) Cre-lox recombination under 
the control of a cell-specific promoter allows hereditary labelling of targeted cell 
populations. While lineage history can rarely be inferred for an individual clone at a 
given time, the fate behaviour of cell populations can often be recovered from the 
quantitative analysis of a statistical distribution of clones. (b) Confocal images of 
EYFP+ basal cells in clones of mouse ear interfollicular epidermis obtained using 
AhcreERT R26EYFP/wt mice at 6 months and one-year post induction [58]. Scale bar 
is 20 m. (c) The Mosaic Analysis with Double Markers (MADM) system relies on 
Cre-induced mitotic recombination. Fluorescent reporter genes of distinct color can 
be activated in two sister cells, leading to the expression of one or two markers. 
Definitive lineage information can be recovered from clones stemming from sister 
cells labelled in different colors. (d) Example of a MADM clone derived from mouse 
neocortex using Nestin-CreERT2;MADM showing lineage labelled neurons and glia. 
Sister cells are marked in YFP and RFP (S. Hippenmeyer, unpublished). (e) H2B-GFP is 
stably and homogeneously expressed in cycling cells. Upon DOX administration GFP 
intensity is halved at each round of cell division such that GFP levels record 
information about the number of cell divisions a given cell has undergone between 
DOX administration and analysis. (f) H2B-GFP dilution demonstrates regional 
variability in proliferation in mouse tail interfollicular epidermis [29]. Confocal image 
of H2B–GFP immunostaining in unchased mice (left) and 6 weeks after DOX 
administration (right). Slow-cycling cells are preferentially localised at the bottom of 
epidermal undulations (stars). Dashed lines are hair follicles. Scale bars denote 
20 μm. (g) Intra-vital imaging provides spatial and temporal lineage information 
during a specified time window. H Intra-vital imaging of tumour cells in mouse 
mammary tissue, which were photo-converted from green to red using a violet laser. 
By providing spatial information, intra-vital imaging is capable of revealing migration 
patterns of cells [8]. 
 
Figure 2. Quantitative lineage tracing studies provide insight into cell fate 
behaviour in cycling homeostatic tissues. In adult, the fate of dividing stem cells 
(blue) is constrained by the condition of homeostasis. (a) Applied to the turnover of 
mouse oesophagus, quantitative lineage tracing studies using AhcreERT R26EYFP/wt 
show that clonal evolution is consistent with a model in which progenitor divisions 
(at rate  ) results in either two differentiating cells (grey, with probability  ), two 
stem cells (with probability  ) or one stem cells and one differentiating cells (with 
probability     ) [43]. (b) According to this model, the average basal layer clone 
size is predicted to rise linearly over time,      , to compensate for the ever-
diminishing surviving clone fraction. (Points show experimental data and the line 
shows the linear prediction from the stochastic fate model in (a).) (c) The 
corresponding clone size distribution is predicted to conform to a scaling behaviour 
in which the chance of finding a clone with a size larger than some multiple of the 
average remains constant over time and collapses onto an exponential form, 
              (see main text). (Points show data from different time-points post-
induction.) (d) In mouse spermatogenesis, the stochastic loss of germ line stem cells 
through differentiation is perfectly compensated by the duplication of neighbours 
along the one-dimensional seminiferous tubule. In this case, the average clone size is 
predicted to follow a square root time-dependence,        . (Points show data 
obtained using GFRα1-CreERT2;CAG-CAT-EGFP mice and the line shows the 
theoretical prediction.) (e) In this case, the cumulative clone size distribution is also 
predicted to acquire a scaling form with                  . (Points show 
experimental data from multiple time points.) 
 
 
Figure 3. Lineage tracing in the developing mouse heart. (a) Confocal image at low 
magnification of a mosaically labeled heart in Mesp1-Cre/Rosa-Confetti embryo at 
E12 (Figure courtesy of Ref. [50]). (b) Due to cell migration and tissue deformation, 
labelled clones often fragment into disconnected clusters in developing tissues. 
Using Confetti labeling, Mesp1 expressing cells were constitutively labelled during 
gastrulation. Image shows whole mount of a mouse heart analysed at E12.5 (from 
[49]). (c) In a situation where induction was almost clonal, Lescroart et al. used 
statistical inference to reconstruct the clonal provenance of fragmented clusters. 
Using this approach, the time points of lineage specification of Mesp1 precursors to 
the two heart fields could be inferred. The plot shows the frequency of Mesp1 
expressing cells contributing to either the first (FHF) or the second heart field (SHF). 
(c) As in heart, where only the surface touching portion of fragments is accessible, 
clonal data is often sectional. While the full clone size cannot be reconstructed from 
sectional data, taking into account processes corresponding to the transfer of cells 
between layers their fate behavior can nevertheless be partly recovered. (e) For 
symmetrically dividing cells, the size distribution obtains a negative-binomial form 
(blue line), matching the cumulative clone size distribution (black line) and s.e.m. 
(gray) of E6.25 (FHF-enriched population) and E7.25 (SHF-enriched population) 
induced monoclonal-labeled hearts, showing the existence of equipotent 
progenitors inside these two populations of cardiac progenitors.  
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